Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients
Supplemental Digital Content is available in the text
Main Authors: | Demir, Münevver, Grünewald, Friederike, Lang, Sonja, Schramm, Christoph, Bowe, Andrea, Mück, Vera, Kütting, Fabian, Goeser, Tobias, Steffen, Hans-Michael |
---|---|
Format: | Online |
Language: | English |
Published: |
Wolters Kluwer Health
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044885/ |
Similar Items
-
Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis
by: Ping Zhang, et al.
Published: (2018-08-01) -
FIB the fractured femur
by: Shahzad, H, et al.
Published: (2013) -
Sputtering of paraboloid microstructure using fib
by: Ali, Mohammad Yeakub, et al.
Published: (2006) -
Surface roughness of FIB sputtered silicon
by: Ali, Mohammad Yeakub, et al.
Published: (2001) -
Study on Post-Treatment Relapse in HBeAg Positive CHB Patients
by: Lu, Junfeng, et al.
Published: (2015)